The scope of this contract with DHSC is for a phased national roll-out over a three month period in care homes, GP practices and selected private sector organisations with large workforces. Revenues will be shared with Excalibur Healthcare Services Limited under the terms of the exclusive agreement between the two companies.
Lord (Paul) Drayson PhD, CEO of Sensyne Health, said:
“This is a significant commercial milestone in Sensyne’s development and underline’s the potential of our world-class expertise in clinical AI applied to diagnostic testing. We are delighted to be working with the Dept of Health & Social Care to support the UK’s national COVID testing programme, which is making a huge impact in helping the nation to recover from the pandemic.”